Welcome to
|
Revolutionizing the way viruses and bacteria are detected and diagnosed
|
Welcome to
|
Revolutionizing the way viruses and bacteria are detected and diagnosed
|
MISSION
|
|
Guanine's mission is to contain pandemics by decentralizng pathogen testing with handheld testing instruments and rapid, simple, inexpensive and accurate tests. This will empower companies, individuals and government agencies to test whoever and whenever they want to rapidly identify viruses and bacteria while the infections are easier to be contained. With the use of AI tools individuals can make better-informed decisions such as urgently seeing a doctor at the early stage of infections when virulent pathogens are more easily treated and at a lower cost.
|
TECHNOLOGY
|
|
Guanine has developed a handheld electronic sensor and automated test cartridge that can allow businesses and consumers to detect specific viruses and bacteria with PCR accuracy in minutes at 25-50% of the cost of lab tests. Here’s how:
|
|
BEYOND COVID-19
The world beyond COVID-19
"COVID-19 has shown the inability of the centralized lab testing infrastructure to prevent a pandemic from devastating businesses and disrupting human lives. We need a better approach before the next pandemic."
Neil Gordon Founder and CEO, Guanine Inc. |
![]() Neil Gordon B.Eng, MBA
President & CEO email LinkedIn Neil is a business executive specializing in managing advanced technology products and ventures. He was one of the one of first business consultants in nanotechnology. He headed commercialization for the NASA-led CANEUS and spun out a company from NASA’s Ames Research Center to commercialize NASA’s carbon nanotube sensor. He co-developed a testing instrument for detecting RNA from bacteria and viruses. He subsequently invented and patented the quadruplex detection tag, the electronic sensor, and AI diagnosis platform. |
![]() Garry Palmateer M.Sc.
Vice President, Assays Garry is a microbiologist with over 40 years experience in detecting bacteria and viruses. Garry previously operated pathogen testing labs in the private sector and for the Ontario Government. He oversaw remediation of the Walkerton E.coli outbreak. Garry co-developed the pathogen sensor and inline testing instrument at Guanine's predecessor NASA spin-off company. He developed assay protocols for various pathogens including a rapid test for carbapenem resistance using the electronic sensor. |
|
|